| Structure |
Chemical Name |
CAS |
MF |
 |
Tofacitinib Impurity 105 |
|
|
 |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
|
C16H14N2O3S |
 |
4-Methoxy-2,3,5-trimethylpyride-N-oxide |
86604-80-0 |
C9H13NO2 |
![4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-3-sulfonamide](/) |
4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-3-sulfonamide |
|
|
 |
Ornidazole Impurity J |
742020-47-9 |
C7H12N4O3 |
 |
Hydroxy Flunarizine |
87166-81-2 |
C26H26F2N2O |
 |
Linagliptin Impurity F |
1673546-62-7 |
C27H27F3N8O3 |
 |
Topiroxostat Impurity 4 |
|
|
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](/CAS/20200611/GIF/1564265-95-7.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-95-7 |
C18H25N3O2 |
 |
(3S,4R)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1593543-00-0 |
C24H21F2NO3 |
 |
(S)-BoroLeu-(-)-Pinanediol-CF3COOH |
477254-69-6 |
C17H29BF3NO4 |
 |
2-amino-3,5-dibromo-N-((1r,4r)-4-hydroxycyclohexyl)benzamide |
105735-86-2 |
C13H16Br2N2O2 |
![(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid](/CAS/GIF/205826-86-4.gif) |
(R)-α-[(2,2-DiMethyl-1-oxopropyl)aMino]-4-hydroxybenzeneacetic Acid |
205826-86-4 |
C13H17NO4 |
 |
Nirmatrelvir Impurity 9 |
|
|
 |
Hyoscine Butylbromide EP Impurity D |
|
|
 |
(R)-N-((S)-2-aminobutanoyl)-3-(bromomethyl)hexanamide |
|
C11H21BrN2O2 |
![(3RS)-1,3-Bis[4-(2-Methylpropyl) phenyl]butan-1-one](/CAS/20130318/GIF/CB12605026.gif) |
(3RS)-1,3-Bis[4-(2-Methylpropyl) phenyl]butan-1-one |
|
C24H32O |
 |
Canagliflozin Impurity 23 |
|
|
 |
Aprepitant iMpurity 45 |
|
|
 |
Atracurium Impurity E |
|
|
 |
Brivaracet amoxidation Impurity 2 |
|
|
 |
SalMeterol iMpurity |
144391-74-2 |
C25H37NO4 |
 |
DESMETHYL ATOMOXETINE HYDROCHLORIDE |
881995-46-6 |
C16H19NO.ClH |
 |
Canagliflozin Impurity 48 |
|
|
 |
Cyclosporine iMpurity |
|
|
![3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one](/CAS/GIF/153139-56-1.gif) |
3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
153139-56-1 |
C16H20N2O |
 |
1H-Benzimidazole, 6-bromo-2-methyl-4-(phenylmethoxy)- |
774582-60-4 |
C15H13BrN2O |
 |
AztreonaM IMpurity F |
102579-57-7 |
C15H21N5O8S2 |
![3-[(2-[(E)-2-(3-ETHYL-1,3-BENZOTHIAZOL-3-IUM-2-YL)ETHENYL]-6-((E)-2-[3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]ETHYLIDENE)-4-METHYL-1-CYCLOHEXEN-1-YL)OXY]-1-PROPANESULFONATE](/StructureFile/ChemBookStructure21/GIF/CB8801272.gif) |
3-[(2-[(E)-2-(3-ETHYL-1,3-BENZOTHIAZOL-3-IUM-2-YL)ETHENYL]-6-((E)-2-[3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]ETHYLIDENE)-4-METHYL-1-CYCLOHEXEN-1-YL)OXY]-1-PROPANESULFONATE |
|
C32H36N2O4S3 |
 |
ノルリドカイン塩酸塩 |
7729-94-4 |
C12H18N2O.ClH |
 |
N-Isopropyl Carvedilol |
1246819-01-1 |
C27H32N2O4 |
 |
α-メチル-4-(ブロモメチル)フェニル酢酸メチル |
99807-54-2 |
C11H13BrO2 |
 |
4-(4-メチルピペラジン-1-イルメチル)安息香酸 |
106261-48-7 |
C13H18N2O2 |
 |
Flucloxacillin Impurity |
|
|
![Acetamide, N-[2-hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]-N-(1-methylethyl)-](/CAS/20200515/GIF/66722-65-4.gif) |
Acetamide, N-[2-hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]-N-(1-methylethyl)- |
66722-65-4 |
C20H33NO5 |
![(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB32735563.gif) |
(1S,2S,3R,5S)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C14H20ClN5O4S |
 |
Amoxicillin Oxidized Impurities |
|
|
 |
2-(3-cyano-4-isobutoxyphenyl)-N,N,4-trimethylthiazole-5- carboxamide |
1380049-45-5 |
C18H21N3O2S |
 |
(E)-8-(3,4-dimethoxystyryl) |
|
|
 |
Tolvaptan impurity3 |
|
|
 |
2-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-N,β-diphenyl-benzenebutanamide |
1797905-42-0 |
C26H24FNO3 |
 |
((2R,3S,4R,5R,6S)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl) methyl)-4-methylphenyl)-3,4,5-trihydroxytetrahydro- 2H-pyran-2-yl)methyl acetate |
2146135-87-5 |
C26H27FO6S |
![4-(3-メチルフェニル)-2H-ピリド[4,3-E]-1,2,4-チアジアジン-3(4H)-オン1,1-ジオキシド SODIUM SALT (TORSEMIDE IMPURITY)](/CAS/GIF/72810-61-8.gif) |
4-(3-メチルフェニル)-2H-ピリド[4,3-E]-1,2,4-チアジアジン-3(4H)-オン1,1-ジオキシド SODIUM SALT (TORSEMIDE IMPURITY) |
72810-61-8 |
C13H11N3O3S |
 |
Liquiritigenin-7-O-apiosyl(1-2)-glucoside |
135432-48-3 |
C26H30O13 |
 |
4-(4-Piperidyl)-1-butanol |
57614-92-3 |
C9H19NO |
![methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/38990-16-8.gif) |
methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
38990-16-8 |
C21H26N2O3 |
 |
オリビル 4-O-グルコシド |
76880-93-8 |
C26H34O12 |
 |
Febuxostat Impurity 43 |
|
|
![3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-](/CAS/20210305/GIF/2468737-92-8.gif) |
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-92-8 |
C25H27Cl2N5O3 |
 |
PREDNICARBATE RELATED COMPOUND C (プレドニゾロン-21-プロピオン酸) |
5740-62-5 |
C24H32O6 |
 |
(R)-3-((R)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium |
|
C19H28NO3+ |
![7-[(2-aMinoethyl)aMino] -1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20150408/GIF/CB92679157.gif) |
7-[(2-aMinoethyl)aMino] -1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
C14H16FN3O3 |
 |
(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide |
1006614-51-2 |
C10H9F2NO |
 |
4-アミノフルオレセイン |
3326-34-9 |
C20H13NO5 |
 |
2-クロロ-N-(2,3-ジメチルフェニル)アセトアミド |
2564-07-0 |
C10H12ClNO |
 |
Nilotinib N-Oxide Impurity 4 |
|
|
 |
Ambroxol Impurity 8(Ambroxol Impurity M) |
1445719-53-8 |
C13H16Br2N2O |
 |
(4S,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester |
186508-95-2 |
C14H23NO4 |
![[6R-[6α,7β(R*)]]-7-[(AMinophenylacetyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0](/CAS/20150408/GIF/79750-46-2.gif) |
[6R-[6α,7β(R*)]]-7-[(AMinophenylacetyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0 |
79750-46-2 |
C16H17N3O4S |
 |
Irbesartan Impurity 5 |
1213252-81-3 |
C25H28N6O |
![Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide)](/CAS/20180808/GIF/104517-96-6.gif) |
Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide) |
104517-96-6 |
C18H24I3N3O9 |
 |
Cefdinir Impurity PQ(CP) |
|
|
![3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-](/CAS/20210305/GIF/2626934-45-8.gif) |
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- |
2626934-45-8 |
C25H30Cl2N6OS2 |
 |
2-(4-ヒドロキシフェニル)-5-ヒドロキシ-3,7-ビス(β-D-グルコピラノシルオキシ)-4H-1-ベンゾピラン-4-オン |
25615-14-9 |
C27H30O16 |
![3-(1,4-Dihydro-5-Methyl-4-oxo-7-propyliMidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzoic Acid](/CAS/GIF/358390-39-3.gif) |
3-(1,4-Dihydro-5-Methyl-4-oxo-7-propyliMidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxybenzoic Acid |
358390-39-3 |
C18H20N4O4 |
 |
(2R,3S)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)-N-(4-((2R,3S)-1-(2-fluoro-6-methylbenzoyl)-3-((4-methyl-3-(trifluoromethyl)phenyl)carbamoyl)piperidin-2-yl)phenyl)piperidine-3-carboxamide |
|
|
 |
8-Hydroxy Entecavir |
1795791-10-4 |
C12H15N5O4 |
 |
(3R,5R)-Fluvastatin Sodium Salt |
194934-99-1 |
C24H27FNNaO4 |
 |
Rosuvastatin Impurity 152 |
|
|
 |
Atracurium Impurity W |
|
|
 |
He-H2-Ar ternary mixture |
|
|
 |
Exatecan Metabolite 1 (UM-1 (1RS)-Isomer) Acetate (Mixture of Diastereomers) |
|
|
 |
Riociguat Impurtiy 4 |
|
|
![(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide](/CAS/20180629/GIF/1223404-68-9.gif) |
(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
1223404-68-9 |
C21H22F2N6O2 |
 |
1-Ethyl-2-[[(2-methoxy-5-sulphamoyl |
|
|
![N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide](/CAS/20150408/GIF/168626-93-5.gif) |
N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide |
168626-93-5 |
C32H25N3O3 |
 |
Levofloxacin Impurity 24 |
|
C18H20FN3O4 |
 |
Ticagrelor Impurity 13 |
|
|
 |
Oseltamivir Impurity (MW:468Da) |
|
|
 |
ヒドロキシボセンタン |
253688-60-7 |
C27H29N5O7S |
![N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide](/CAS/20200119/GIF/1374226-74-0.gif) |
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide |
1374226-74-0 |
C18H24N2O |
 |
Valsartan cyano analog methyl ester |
137863-90-2 |
C25H30N2O3 |
 |
FaMotidine iMpurity |
130463-35-3 |
C5H8N4S2.Na |
 |
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate |
1194550-67-8 |
C36H30Cl2N2O7S |
 |
Imatinib Impurity 4 |
942514-62-7 |
C30H33N7O |
![3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2504210-48-2.gif) |
3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile |
2504210-48-2 |
C22H23N9O |
 |
Levothyroxine EP Impurity B |
1628720-66-0 |
C15H11ClI3NO4 |
![2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol](/CAS/20150408/GIF/CB02668497.gif) |
2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
1858267-99-8 |
C17H26N6O4S |
 |
Vitamin B12 e-Monocarboxylic Acid |
26264-28-8 |
C63H87CoN13O15P |
 |
9-Piperazino Ofloxacin |
197291-75-1 |
C18H20FN3O4 |
 |
Pramipexole impurity II |
|
|
 |
IpratropiuM BroMide IMpurity E |
183626-76-8 |
C19H27NO3 |
 |
Nicorandil Impurity 2 |
|
|
 |
Febuxostat Impurity 8 |
144060-62-8 |
C16H17NO4S |
 |
Febuxostat Bromo Impurity |
144060-40-2 |
C15H16BrNO3S |
![(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride](/CAS/20150408/GIF/1333998-21-2.gif) |
(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride |
1333998-21-2 |
C20H19ClF7NO2 |
 |
6-(1-methyl-1H-indazol-5-yl)pyrimidin-4-ol |
|
|
 |
(1R,3R)-Solifenacin Succinate 2 |
740780-79-4 |
C23H26N2O2 |
 |
Topiroxostat Impurity 14 |
|
|
 |
Alogliptin Impurity E |
|
|